CD20 antigen on pre-B and mature B-lymphocytes — Drug Target
All drugs that target CD20 antigen on pre-B and mature B-lymphocytes — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Mabthera · Roche · Monoclonal antibody · Oncology
Monoclonal antibody targeting CD20 on B-lymphocytes, mediating cell lysis via CDC and ADCC.